GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

111 papers

Active filtersClassification:Supporting

Showing 49-60 of total 111 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Evidence-Based Management and Functional Outcomes of Femoral Head Avascular Necrosis: A Systematic Review.

Desai S; Shinde S; Desai R; Mane M; Shinde A

Jan 1, 2026

2026PubMedSupporting evidence

Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials.

Shao C; Lin H; Yu J; Chen H; Ren Y; Ren J; Zeng Y; Wu Y; Bai H; Zhang Q; Xiao X

Jan 1, 2026Diabetes, metabolic syndrome and obesity : targets and therapy

2026PubMedSupporting evidence

Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study.

Tu CY; Chen HL; Wu YH; Wu MJ

Jan 1, 2026Diabetes research and clinical practice

2026PubMedSupporting evidence

Unimolecular GLP-1/APJ receptor co-agonism improves metabolism and dyslipidaemia as well as normalising hepatic triglyceride and aminotransferase elevation in high-fat-fed mice.

Sridhar A; Palmer ES; Craig SL; Tanday N; O'Harte FPM; Irwin N

Jan 1, 2026Diabetologia

2026PubMedSupporting evidence

Liraglutide and renal mitochondrial homeostasis: targeting the "metabolism-inflammation-lithogenesis" axis in metabolic syndrome.

Wang F; Li Q; Wen Q; Su B; Zhou H; Fu Y; Chen H; He Q

Jan 1, 2026Frontiers in pharmacology

2026PubMedSupporting evidence

Intralesional bleomycin versus cryotherapy for the treatment of common warts: a systematic review and meta-analysis of randomized controlled trials.

Lucero Calvache DA; Peláez Vélez LC; Maldonado Carrasco CL; Loayza E

Jan 1, 2026Actas dermo-sifiliograficas

2026PubMedSupporting evidence

Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial.

Ostrominski JW; Plutzky J; Scirica BM; Hovingh GK; Jeppesen OK; Lincoff AM; Lingvay I; Hoffmann Morville T; Quiroga M; Sofer Y; Urina-Triana M; Aroda VR; SELECT Trial Investigators

Jan 1, 2026JAMA cardiology

2026PubMedSupporting evidence

Efficacy and safety of orforglipron 12 mg versus orforglipron 36 mg maintenance dose among patients with obesity with or without diabetes: a systematic review and comprehensive meta-analysis.

Hegaz MG; Aboud MYA; Kamel AII; Naveed MA; Elsayed OG; Sorathia AZ

Jan 1, 2026BMC endocrine disorders

2026PubMedSupporting evidence

Therapeutic modulation of the gut-brain axis in alcohol use disorder: A systematic review.

Bhandari P; Sideeg A; Elfeki M; Xie C; Singal AK

Jan 1, 2026Metabolism open

2026PubMedSupporting evidence

Glucagon-like peptide-1 receptor agonists as adjunctive therapy in refractory hypertriglyceridemia following recurrent pancreatitis.

Miura D; Nicholls S; Joham AE; Braude M; Tay CT

Jan 1, 2026JCEM case reports

2026PubMedSupporting evidence

Do Preoperative Glucagon-Like Peptide-1 Receptor Agonists Influence Lumbar Fusion Outcomes? A Systematic Review and Meta-Analysis.

Alves MLM; Moura Costa AODS; Costa JDVM; Ferreira JSN; Porto LLB; Garrido GA; Gonzalez JVP; Tome JOD; Rodrigues LMR; Pereira BA

Jan 1, 2026International journal of spine surgery

2026PubMedSupporting evidence

Minimally Invasive vs Open Surgery for the Treatment of Spinal Spondylodiscitis: A Systematic Review and Meta-Analysis.

Tomé JOD; de Souza RC; Santana RV; de Oliveira WH; Motter BV; Foizer GA; César AEM; Rodrigues LMR

Jan 1, 2026International journal of spine surgery